Trial intelligence / Profile preview

Tranexamic acid for haemarthrosis after arthroscopic meniscectomy

ACTRN12618000734268Phase 3Recruiting

Sponsor
Professor Gary Hooper
Start
Apr 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in hemarthrosis comparing Tranexamic acid with Placebo (2 arms). Primary endpoint: Visual analogue scale pain. Started Apr 2018; status: recruiting.

02

Drugs

tranexamic acid
03

Conditions

hemarthrosis

Beyond the preview

Go deeper on ACTRN12618000734268.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12618000734268.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call